NRNP 6675 Week 6 Midterm
Exam Prep Questions and
Correct Answers Latest 2025-
2026/ Nrnp 6675 Psychiatric
Mental Health Nurse
Practitioner Midterm Test
NRNP 6675 PMHNP
pg. 0
, lOMoAR cPSD| 26766204
1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all
that apply Age
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing
which of the following effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS) Causes prolactinemia
Reduces positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects by blocking
which of the following receptors?
GABA type
receptors
Serotonin
receptors
pg. 1
, lOMoAR cPSD| 26766204
Dopamine receptors
NMDA type receptors
4. The diagnosis used to describe a syndrome characterized by specific signs and symptoms
resulting from recent ingestion or exposure to a substance is known as which of the
following?
Substance
intoxication
Substance
withdrawal
Substance use
disorder
Any of the above
5. Abnormal involuntary movements in a rhythmic pattern affecting face, mouth, tongue,
jaw is known as which of the following?
Akathisi
a
Dystoni
a
Tardive dyskinesia
Extrapyramidal side
effects
6. A deeply held belief despite evidence to the contrary, lasting at least one month, without
prominent hallucinations, with functional impairment that relates to the delusional syste.....
Schizophrenia
Delusional disorder
pg. 2
, lOMoAR cPSD| 26766204
Brief psychotic
disorder
Schizophreniform disorder
pg. 3
Exam Prep Questions and
Correct Answers Latest 2025-
2026/ Nrnp 6675 Psychiatric
Mental Health Nurse
Practitioner Midterm Test
NRNP 6675 PMHNP
pg. 0
, lOMoAR cPSD| 26766204
1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all
that apply Age
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing
which of the following effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS) Causes prolactinemia
Reduces positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects by blocking
which of the following receptors?
GABA type
receptors
Serotonin
receptors
pg. 1
, lOMoAR cPSD| 26766204
Dopamine receptors
NMDA type receptors
4. The diagnosis used to describe a syndrome characterized by specific signs and symptoms
resulting from recent ingestion or exposure to a substance is known as which of the
following?
Substance
intoxication
Substance
withdrawal
Substance use
disorder
Any of the above
5. Abnormal involuntary movements in a rhythmic pattern affecting face, mouth, tongue,
jaw is known as which of the following?
Akathisi
a
Dystoni
a
Tardive dyskinesia
Extrapyramidal side
effects
6. A deeply held belief despite evidence to the contrary, lasting at least one month, without
prominent hallucinations, with functional impairment that relates to the delusional syste.....
Schizophrenia
Delusional disorder
pg. 2
, lOMoAR cPSD| 26766204
Brief psychotic
disorder
Schizophreniform disorder
pg. 3
